Literature DB >> 22278639

Metabolic syndrome and insulin resistance in migraine.

Sanjeev K Bhoi1, Jayantee Kalita, Usha K Misra.   

Abstract

Metabolic syndrome is associated with migraine but there is no study comparing the characteristics of migraine with and without metabolic syndrome from Southeast Asia. This study was therefore undertaken to compare the clinical characteristics of migraine in patients with and without metabolic syndrome and insulin resistance. 135 consecutive patients with migraine diagnosed on the basis of International Headache Society criteria were subjected to clinical evaluation as per fixed protocol. Headache severity, frequency and functional disability were recorded. Metabolic syndrome was diagnosed as per National Cholesterol Education Programme: Adult Treatment Panel III and International Diabetic Federation criteria. Insulin resistance was calculated by homeostases model assessment. Their age ranged between 14 and 61 years and 108 were females. Metabolic syndrome was present in 31.9% patients and only 13 were obese. Insulin resistance was present in 11.1%. Metabolic syndrome was correlated with age, gender, number of triggers, years of headache and duration of migraine attacks. Insulin resistance correlated with duration of migraine attacks. From this study, it can be concluded that metabolic syndrome was present in 31.9% of the migraineurs which was mainly in elderly who had longer duration of headache and multiple triggers.

Entities:  

Mesh:

Year:  2012        PMID: 22278639      PMCID: PMC3356472          DOI: 10.1007/s10194-012-0416-y

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  26 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Glucose and diet in the fasting migraineur.

Authors:  J B Marsters; M J Mortimer; K M Hay
Journal:  Headache       Date:  1986-05       Impact factor: 5.887

3.  Hypothalamic-pituitary-adrenal axis studies in migraine with special reference to insulin sensitivity.

Authors:  N S Rao; J Pearce
Journal:  Brain       Date:  1971       Impact factor: 13.501

4.  2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Authors:  R B Lipton; W F Stewart; R Cady; C Hall; S O'Quinn; T Kuhn; D Gutterman
Journal:  Headache       Date:  2000 Nov-Dec       Impact factor: 5.887

5.  Obesity and migraine: a population study.

Authors:  Marcelo E Bigal; Joshua N Liberman; Richard B Lipton
Journal:  Neurology       Date:  2005-12-14       Impact factor: 9.910

6.  Insulin sensitivity is impaired in patients with migraine.

Authors:  I Rainero; P Limone; M Ferrero; W Valfrè; C Pelissetto; E Rubino; S Gentile; R Lo Giudice; L Pinessi
Journal:  Cephalalgia       Date:  2005-08       Impact factor: 6.292

7.  Body mass index, migraine, migraine frequency and migraine features in women.

Authors:  A C Winter; K Berger; J E Buring; T Kurth
Journal:  Cephalalgia       Date:  2009-02       Impact factor: 6.292

Review 8.  [Metabolic syndrome and prevention of migraine headache].

Authors:  Takao Takeshima
Journal:  Brain Nerve       Date:  2009-10

9.  Insulin resistance and high sensitivity C-reactive protein in migraine.

Authors:  Baburhan Guldiken; Sibel Guldiken; Muzaffer Demir; Nilda Turgut; Levent Kabayel; Hulya Ozkan; Emine Ozcelik; Armagan Tugrul
Journal:  Can J Neurol Sci       Date:  2008-09       Impact factor: 2.104

10.  Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population.

Authors:  S Yadav; R Boddula; G Genitta; V Bhatia; B Bansal; S Kongara; S Julka; A Kumar; H K Singh; V Ramesh; E Bhatia
Journal:  Indian J Med Res       Date:  2008-12       Impact factor: 2.375

View more
  16 in total

1.  Non-alcoholic fatty liver disease in patients with migraine.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Aylin Okur; Serkan Dogan; Elif Borekci; Mustafa Kozan; Sebnem Gursoy
Journal:  Neurol Sci       Date:  2014-04-23       Impact factor: 3.307

Review 2.  Obesity and headache: part I--a systematic review of the epidemiology of obesity and headache.

Authors:  Nu Cindy Chai; Ann I Scher; Abhay Moghekar; Dale S Bond; B Lee Peterlin
Journal:  Headache       Date:  2014-02       Impact factor: 5.887

Review 3.  Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article.

Authors:  Nahid Sarahian; Mahsa Noroozzadeh; Marzieh Saei Ghare Naz; Narges Eskandari-Roozbahani; Fatemeh Mahboobifard; Fahimeh Ramezani Tehrani
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

4.  High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.

Authors:  Usha K Misra; Jayantee Kalita; Sanjeev K Bhoi
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

5.  Low fetuin-A level in migraine: a case-control study.

Authors:  Mehmet Halis Tanriverdi; Sefer Varol; Adalet Arikanoglu; Pakize Gamze Erten Bucaktepe; Tahsin Celepkolu; Esref Akil; Hatice Yuksel; Ertugrul Uzar
Journal:  Neurol Sci       Date:  2013-08-08       Impact factor: 3.307

Review 6.  Is Migraine Primarily a Metaboloendocrine Disorder?

Authors:  Innocenzo Rainero; Flora Govone; Annalisa Gai; Alessandro Vacca; Elisa Rubino
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

7.  Metabolic syndrome in migraine headache: A case-control study.

Authors:  Mehrzad Salmasi; Laya Amini; Shaghayegh Haghjooy Javanmard; Mohammad Saadatnia
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

Review 8.  Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Authors:  Eduardo Rivera-Mancilla; Linda Al-Hassany; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

Review 9.  New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

Authors:  Claudio Tana; Emmanuele Tafuri; Marco Tana; Paolo Martelletti; Andrea Negro; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini; Andrea Mezzetti; Maria Adele Giamberardino
Journal:  J Headache Pain       Date:  2013-02-01       Impact factor: 7.277

10.  Does Metabolic Syndrome Determine Severity and Disability of Chronic Low Backache?

Authors:  Jayantee Kalita; Kamlesh Kumar Sonkar; Usha Kant Misra; Sanjeev K Bhoi
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.